Signature Resources Capital Management’s KraneShares Asia Pacific High Income Bond ETF KHYB Stock Holding History

Signature Resources Capital Management’s Portfolio KHYB Stock Details KHYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-23	Closed	-$577	–	387
2024 Q3	$577	Hold	23	–	–	﹤0.01%	357
2024 Q2	$568	Hold	23	–	–	﹤0.01%	387
2024 Q1	$553	Hold	23	–	–	﹤0.01%	375
2023 Q4	$553	Buy	+23	New	+$573	﹤0.01%	376

Other funds holding KHYB

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Signature Resources Capital Management's KHYB Position: Q4 2024 in Review

Signature Resources Capital Management sold out of KraneShares Asia Pacific High Income Bond ETF (KHYB) in Q4 2024, closing a stake of 23 shares — an estimated $577 sold.

Signature Resources Capital Management first reported a position in KHYB in Q4 2023 and held it in 4 quarters. The position peaked at $577 in Q3 2024. 5 funds tracked by Wall St. Rank hold KHYB as of Q4 2024.

Signature Resources Capital Management reported no remaining KraneShares Asia Pacific High Income Bond ETF position as of Q4 2024 after selling out during the quarter.
Signature Resources Capital Management sold 23 KraneShares Asia Pacific High Income Bond ETF shares in Q4 2024, an estimated $577.
Signature Resources Capital Management first reported a position in KraneShares Asia Pacific High Income Bond ETF in Q4 2023 and held it in 4 quarters.
Signature Resources Capital Management's KraneShares Asia Pacific High Income Bond ETF position peaked at $577 in Q3 2024.
5 funds tracked by Wall St. Rank held KraneShares Asia Pacific High Income Bond ETF as of Q4 2024.

Based on Signature Resources Capital Management's 13F filing for Q4 2024, filed 17 Jan 2025.